Samuel N. Hazen - 16 Feb 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
16 Feb 2024
Net transactions value
-$9,375,909
Form type
4
Filing time
21 Feb 2024, 19:31:11 UTC
Previous filing
02 Feb 2024
Next filing
08 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +78,440 +36% $0.000000 296,131 16 Feb 2024 Direct F1
transaction HCA Common Stock Tax liability $9,375,909 -30,387 -10% $308.55 265,744 16 Feb 2024 Direct
holding HCA Common Stock 813,320 16 Feb 2024 By LP
holding HCA Common Stock 233,585 16 Feb 2024 By 2022 GRAT
holding HCA Common Stock 7,864 16 Feb 2024 By HD Trust
holding HCA Common Stock 4,647 16 Feb 2024 By 2009 Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 3, 2021, the reporting person was granted 39,220 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested at 11:01 p.m. Central Time on February 16, 2024 equaled 200% of the units granted.